Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Jacobs Solutions
J
$16.9B
| $3.06M | ﹤0.01% |
+43,627
| New | +$2.94M |
|
1927
First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF
HYLS
$1.64B
| $3.04M | ﹤0.01% |
66,400
+55,800
| +526% | +$2.53M |
|
|
TBHC
1928
DELISTED
The Brand House Collective
TBHC
| $3.04M | ﹤0.01% |
1,121,900
+89,900
| +9% | +$111K |
|
|
AIOS
1929
AIOS Tech
AIOS
$39M
| $3.03M | ﹤0.01% |
920
+181
| +24% | +$455K |
|
1930
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.32B
| $3.02M | ﹤0.01% |
+29,900
| New | +$2.98M |
|
1931
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.9B
| $3.01M | ﹤0.01% |
+36,900
| New | +$2.97M |
|
1932
State Street SPDR S&P Biotech ETF
XBI
$10.3B
| $3.01M | ﹤0.01% |
+26,900
| New | +$2.65M |
|
|
ITIC
1933
Investors Title Co
ITIC
$543M
| $3.01M | ﹤0.01% |
24,800
-100
| -0.4% | -$12.5K |
|
|
IVAC
1934
DELISTED
Intevac Inc
IVAC
| $3.01M | ﹤0.01% |
551,077
-16,700
| -3% | -$86.9K |
|
1935
Byline Bancorp
BY
$1.78B
| $3.01M | ﹤0.01% |
229,600
-104,100
| -31% | -$1.19M |
|
|
MRLN
1936
DELISTED
Marlin Business Services Corp
MRLN
| $3.01M | ﹤0.01% |
355,371
+4,801
| +1% | +$37.2K |
|
|
SII
1937
Sprott
SII
$3B
| $3M | ﹤0.01% |
+83,690
| New | +$2.9M |
|
|
MPX
1938
DELISTED
Marine Products Corp
MPX
| $3M | ﹤0.01% |
216,902
-29,900
| -12% | -$314K |
|
|
NH
1939
DELISTED
NantHealth, Inc
NH
| $3M | ﹤0.01% |
43,634
+460
| +1% | +$18.3K |
|
1940
iShares China Large-Cap ETF
FXI
$4.16B
| $3M | ﹤0.01% |
+75,500
| New | +$2.94M |
|
1941
Nexa Resources
NEXA
$1.88B
| $2.99M | ﹤0.01% |
450,000
-50,500
| -10% | -$224K |
|
1942
V2X
VVX
$2.6B
| $2.99M | ﹤0.01% |
60,800
-48,600
| -44% | -$2.35M |
|
|
GEN
1943
DELISTED
Genesis Healthcare, Inc.
GEN
| $2.98M | ﹤0.01% |
4,312,063
-25,210
| -0.6% | -$20.3K |
|
|
WIRE
1944
DELISTED
Encore Wire Corp
WIRE
| $2.97M | ﹤0.01% |
60,800
-8,200
| -12% | -$376K |
|
1945
The Mosaic Company
MOS
$6.87B
| $2.96M | ﹤0.01% |
+236,900
| New | +$2.84M |
|
|
HEES
1946
DELISTED
H&E Equipment Services
HEES
| $2.96M | ﹤0.01% |
+160,300
| New | +$2.55M |
|
|
APTX
1947
DELISTED
Aptinyx Inc. Common Stock
APTX
| $2.96M | ﹤0.01% |
709,614
+190,685
| +37% | +$645K |
|
1948
Badger Meter
BMI
$3.79B
| $2.96M | ﹤0.01% |
47,000
-600
| -1% | -$35.6K |
|
1949
Genasys
GNSS
$78.8M
| $2.95M | ﹤0.01% |
607,836
+191,723
| +46% | +$846K |
|
|
SY
1950
So-Young International
SY
$225M
| $2.95M | ﹤0.01% |
217,700
-3,400
| -2% | -$35.9K |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.